arrow
A

Anat Achiron

sheba academic medical center and tel aviv university
H指数:62
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study

克拉屈滨在复发型多发性硬化中的临床和机制性作用:MAGNIFY-MS研究2年结果

2025-07-310
OA
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study

研究总结:接受克拉屈滨片治疗复发型多发性硬化患者的血液生物标志物动态变化:MAGNIFY-MS研究2年结果

2025-07-040
OAAI
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

克拉屈滨片治疗复发性多发性硬化症患者的血液生物标志物动态: 2年MAGNIFY-MS研究结果

2025-02-030
OAAI
Specific Patterns of Immune Cell Dynamics May Explain the Early Onset and Prolonged Efficacy of Cladribine Tablets A MAGNIFY-MS Substudy

免疫细胞动力学的特定模式可以解释克拉屈滨片的早期发作和长期疗效放大-MS子研究

2023-01-0116
OAAI